Position in ICLR
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$349,157
+$43,736 QoQ
Shares Held
2,010
-27.2% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#270
of 422 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ICLR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026FIRST TRUST ADVISORS LP holds $1,383,676,421 across 25 Diagnostics & Research names. ICLR ranks #24 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | A |
Agilent Technologies, Inc.
|
2,079,578 | $276,230,345 | |
| 2 | ILMN |
Illumina, Inc.
|
907,489 | $159,563,790 | |
| 3 | NEO |
Neogenomics Inc
|
10,113,261 | $147,552,477 | |
| 4 | VCYT |
Veracyte, Inc.
|
2,507,902 | $147,289,084 | |
| 5 | NTRA |
Natera, Inc.
|
511,214 | $138,769,040 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
202,754 | $106,737,815 | |
| 7 | WAT |
Waters Corp /De/
|
272,470 | $102,187,148 | |
| 8 | DGX |
Quest Diagnostics Inc
|
290,970 | $61,671,091 |
All Filings in ICLR
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $349,157 | 2,010 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $305,421 | 2,760 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $429,856 | 2,359 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $284,725 | 1,627 | Shares | Sole | 2025-11-12 | |
| 2025-03-31 | $1,073,038 | 6,132 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $272,413 | 1,299 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $4,654,422 | 16,200 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $27,168,131 | 86,669 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $32,259,934 | 96,026 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $27,928,818 | 98,664 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $25,784,591 | 104,709 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $3,458,014 | 13,821 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,770,475 | 12,971 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,725,133 | 14,029 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $7,026,828 | 38,235 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $5,905,725 | 27,253 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $10,874,366 | 44,710 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $16,025,736 | 51,746 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $4,126,028 | 15,747 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $3,274,906 | 15,843 | Shares | Sole | 2021-10-12 | |
| 2021-03-31 | $3,248,352 | 16,542 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $3,446,271 | 17,675 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $3,587,141 | 18,772 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $3,429,677 | 20,359 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $3,180,088 | 23,383 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||